Literature DB >> 11967112

Ocular toxoplasmosis: more than just what meets the eye.

A L Vallochi1, M V Nakamura, D Schlesinger, M C Martins, C Silveira, R Belfort, L V Rizzo.   

Abstract

Toxoplasma gondii is an intracellular parasite whose life cycle may include the man as an intermediate host. Close to a billion people are infected with this parasite worldwide. Ocular lesions may occur in up to 25% of those individuals infected. The infection may occur intra-uterus, through the placenta when the mother is infected during pregnancy. The parasite may also infect adults after the ingestion of contaminated food products, most notably meats or water. We have shown that although congenital and post-natal (acquired) infection results in similar ocular lesions, the immunological mechanisms behind the development of disease are different. On the other hand, contrary to published data obtained in mice, we were unable to find evidence that the T. gondii express superantigen activity for human lymphocytes. Our findings are important because they suggest that superantigen activity is not important as a pathological mechanism in human disease. Our data also suggest that, whereas the ocular lesion caused by infection after birth is the result of an excessive or dysfunctional immune response, the lesions caused by congenital infection may be due to a lack of an appropriate response to the parasite.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11967112     DOI: 10.1046/j.1365-3083.2002.01052.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  14 in total

1.  Intervacuolar transport and unique topology of GRA14, a novel dense granule protein in Toxoplasma gondii.

Authors:  Michael E Rome; Josh R Beck; Jay M Turetzky; Paul Webster; Peter J Bradley
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

2.  Genetic Polymorphisms in Cytokine Genes in Colombian Patients with Ocular Toxoplasmosis.

Authors:  C A Naranjo-Galvis; A de-la-Torre; L E Mantilla-Muriel; L Beltrán-Angarita; X Elcoroaristizabal-Martín; R McLeod; N Alliey-Rodriguez; I J Begeman; C López de Mesa; J E Gómez-Marín; J C Sepúlveda-Arias
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

3.  Experimental ocular toxoplasmosis in genetically susceptible and resistant mice.

Authors:  Fangli Lu; Shiguang Huang; Mark S Hu; Lloyd H Kasper
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Toxoplasmosis.

Authors:  Sandra K Halonen; Louis M Weiss
Journal:  Handb Clin Neurol       Date:  2013

5.  Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis.

Authors:  Justus G Garweg; Yvonne de Kozak; Brigitte Goldenberg; Matthias Boehnke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-03       Impact factor: 3.117

6.  Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.

Authors:  Adriana Lima Vallochi; Anna Carla Goldberg; Angela Falcai; Rajendranath Ramasawmy; Jorge Kalil; Cláudio Silveira; Rubens Belfort; Luiz Vicente Rizzo
Journal:  Clin Ophthalmol       Date:  2008-12

7.  Increased frequency of anti-retina antibodies in asymptomatic patients with chronic t. gondii infection.

Authors:  Sylvia Regina Temer Cursino; Thaís Boccia da Costa; Joyce Hisae Yamamoto; Luciana Regina Meireles; Maria Antonieta Longo Galvão Silva; Heitor Franco de Andrade Junior
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

Review 8.  Why prevent, diagnose and treat congenital toxoplasmosis?

Authors:  Rima McLeod; Francois Kieffer; Mari Sautter; Tiffany Hosten; Herve Pelloux
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

9.  Ocular toxoplasmosis: the role of retinal pigment epithelium migration in infection.

Authors:  R C Tedesco; R L Smith; S Corte-Real; K S Calabrese
Journal:  Parasitol Res       Date:  2004-02-20       Impact factor: 2.289

10.  Toxoplasma gondii Proliferation Require Down-Regulation of Host Nox4 Expression via Activation of PI3 Kinase/Akt Signaling Pathway.

Authors:  Wei Zhou; Juan-Hua Quan; Young-Ha Lee; Dae-Whan Shin; Guang-Ho Cha
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.